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Clinacanthus nutans (Acanthaceae), locally known as Sabah snake grass, is popularly taken as
prevention as well as treatment for cancer in Malaysia, despite lack of concrete clinical evidence.
However, it is crucial to evaluate potential antagonistic, additive, or synergistic interactions that
may result from the co-treatment of this plant in chemotherapy. In this study, we demonstrate the
drug-herb interaction using combination treatment of C. nutans extracts and cyclophosphamide
on the WRL 68 cell line. Materials and Methods: Aqueous and 70% ethanol extract of C.
nutans leaves were prepared using decoction and maceration methods. MTT assay was used
to test single treatment as well as the combination of C. nutans extract and cyclophosphamide.
Phytochemical profiling and flavonoid were identified using HPLC. Results: C. nutans ethanolic
extract exhibits low antiproliferative activity. A combination of ethanolic extract of C. nutans and
cyclophosphamide at various concentrations resulted in antagonism with combination index values
of 1.413, 1.482, and 1.525. Flavonoids identified in the phytochemical profile of both extracts
were schaftoside, isoorientin, orientin, and vitexin. High flavonoids level in C. nutans ethanolic
extract could potentially interact with metabolic enzymes of the cell line, which might have
affected metabolism and activated the cyclophosphamide. The in vitro data suggested that there
was a potential for drug-herb interactions, which could negatively affect the chemotherapeutic
outcomes. Further investigation should be done in vivo and clinical research model.
Keywords: Clinacanthus nutans; cyclophosphamide; drug-herb interactions; isobologram;
combination index
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INTRODUCTION
Botanical medicine or phytomedicine, commonly known
as herbal medicine, serves medicinal and therapeutic
purposes by utilizing parts of plants such as leaves, roots,
seeds, flowers, berries, or bark (Chikezie & Ojiako, 2015).
In almost every culture worldwide, including America,
Europe, Africa, and also Asia, herbal plants have played
a vital role as medications (Wargovich et al., 2001).
Herbal remedies are mostly promoted as natural and
harmless thus, many countries do not have regulations
that demand the demonstration of its therapeutic efficacy,
safety, or quality (Fasinu et al., 2012). However, previous
studies revealed that drug-herbal medicine interactions
could reduce efficacy or cause failure in drug treatment,
such as chemotherapy treatments. Therapeutic failure
is common in chemotherapy treatment as the effects of
herbal medicine, for example, metabolism induction,
usually lead to lower plasma levels due to the inactivation
of the chemotherapy drug (Meijerman et al., 2006).
Drug-herb interactions may provide benefits in cancer
treatment, such as reducing adverse side effects (Desai et
al., 2008). However, the potentially harmful effects that

may arise from interactions between complementary
herbal medicine and conventional drugs are undeniable.
Consumption of herbs concomitantly with conventional
drugs has become the norm that promoting the potential
of pharmacokinetic or pharmacodynamic drug-herb
interactions as the combination may mimic, increase or
reduce the effects of the drug or the herb which could
result in clinically significant interactions (Hu et al.,
2005).
Cancer patients tend to use the herbal supplement as
complementary treatments and to reduce symptoms.
A survey conducted in a Malaysian tertiary hospital
revealed that 51.6% of 103 breast cancer patients use
Malay traditional/folk medicine, and 34.1% of them use
herbs as complementary and alternative medicine (RajaLexshimi et al., 2013). The patients who self- medicate
with herbs also given chemotherapy drug and drug-herb
interactions are typical, which may lead to problems.
Cyclophosphamide is one of the most successful
anticancer agents that is used in combination with
other antineoplastic agents for the treatment of various
cancers, including breast, lymphoid and pediatric
malignancies (Emadi et al., 2009). This is an alkylating

Copyright @ 2020 Authors. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License
(http:// creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original
author, and source are properly cited.

82

Pharm Sci Res, Vol 7 No 2, 2020

agent and undergoes metabolism by two different
cytochrome P450 pathways, which are 4-hydroxylation,
the activation pathway, and N-dechloroethylation, the
inactivation pathway of the drug (Chen et al., 2004).
Clinacanthus nutans locally known as Sabah Snake
grass, or “Belalai Gajah” is a small shrub classified under
the family of Acanthaceae. Various kinds of C. nutans
products are available in the market, and this plant is
usually consumed as herbal tea in Malaysia (Alam et al.,
2016). This plant exhibits antiviral, anti-inflammatory,
antioxidant, as well as anticancer properties (Chin et al.,
2014). C. nutans has been widely used as an anticancer
remedy without knowing its effects on chemotherapy. A
recent study found that methanol extract of C. nutans at
different concentrations possesses inhibitory activity on
the metabolism of an analgesic drug (aminopyrine) by
CYP3A4 (Quah et al., 2017). In this study, polar extracts
of C. nutans were evaluated for their phytochemical
profiles, antiproliferative activity, and also combination
effect with cyclophosphamide on the normal liver cell
line.
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METHODS
Extraction of Clinacanthus nutans
Dried C. nutans leaves powder was bought from a nursery
located in Kota Bharu, Kelantan andwas extracted
according to the method described previously with
slight modifications (Quah et al., 2017). For ethanolic
extract, 50 mg of a powder sample in 500 mL of 70%
ethanol was sonicated for 30 min. The solvent was then
removed using a rotary evaporator at 40 °C. For aqueous
extraction, a slightly modified method described before
was used (Al-Manhel et al., 2015). 100 g of powdered
sample was boiled in 200 mL of water for 20, 30, and 60
min. The extract then allowed to cool at room temperature
for one hour before vacuum filtered using Whatman No.
1 filter paper. The supernatant of aqueous extract and
residue of ethanolic extract after solvent removal were
frozen at −80 °C and lyophilized using a freeze dryer on
the next day (Bohlooli et al., 2012). Dried extract residue
kept at −20 °C until further analysis. The extraction yield
of each extract was calculated using equation (1).

Percentage extraction yield = (mass of extract / mass of sample) × 100

(1)

Table 1. The percent yield of extraction of C. nutans aqueous extracts and ethanolic extract
Extract code

Extract

A
B
C
D

Aqueous, decoction, 100oC, 20 min
Aqueous, decoction, 100oC, 30 min
Aqueous, decoction, 100oC, 60 min
70% ethanol, sonication, 30 min

%
yield
of extraction
2.92 %
3.56 %
4.42 %
5.81 %

Figure 1. Total phenolic content, TPC (mean ± SEM) and total
flavonoid content, TFC (mean ± SEM) of C. nutans aqueous (C),
and ethanolic (D) extracts. Bars with different letters denoted
that the mean values were significantly different between extracts
(t-test, p < 0.05).
E-ISSN 2477-0612
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Table 2. IC10, IC15, IC25, and IC50 of C.nutans ethanolic extract on WRL 68
Treatment

IC10
(mean ± SEM)

IC15
(mean ± SEM)

IC25
(mean ± SEM)

IC50
(mean ± SEM)

C. nutans ethanolic
extract (mg/mL)

1.223 ± 0.016

1.634 ± 0.014

2.354 ± 0.006

4.051 ± 0.041

Figure 2. HPLC Chromatograms of A: Ethanolic extract
(D) profile, B: Aqueous extract (C) profile and C: Flavonoid
standards (schaftoside, isoorientin, orientin, and vitexin)
Total Phenolic Content

Total Flavonoid Content

The total phenolic content of the extracts was quantified
using the Folin-Ciocalteu reagent (Aziz & Jack, 2015).
10 mg of dried extracts were dissolved in 1 mL of water
and vortexed until homogenous. 1 mL of Folin-Ciocalteu
reagent and 0.8 mL of 7.5% (w/v) sodium bicarbonate
(Na2CO3) were added to 0.2 mL of extract. The mixture
was incubated for 1 hour at room temperature (25-27°C).
The absorbance at 760 nm was measured using a UVVis spectrophotometer. The six-point calibration curve
was plotted with six concentrations of gallic acid (0.02
to 0.30 mg/mL).

A method described previously was used with slight
modification (Kalita et al., 2013). Extracts were prepared
at concentration 1mg/mL in methanol. 500 μL of extract
stock, 1.5 ml methanol, 100 μL 1% aluminum chloride,
100 μL 1M potassium acetate solution, and 2.8 ml
distilled water were mixed in 6 well-plates. Absorbance
was measured at 415 nm after 30 min, incubation at
room temperature. The calibration curve of quercetin at
20, 40, 60, 80, and 100 μg/mL was plotted.

E-ISSN 2477-0612

84

Pharm Sci Res, Vol 7 No 2, 2020

Mutalib, et al.

HPLC Analysis
Prior to analysis, 1 mg of C. nutans extract was dissolved
in 1 mL HPLC grade methanol and filtered through
a PTFE filter (pore size, 0.22 μm). For the extract
phytochemicals profiling, HPLC conditions described
in a previous study was used with modifications
(Chelyn et al., 2014). Extracts were analyzed using
Dionex Ultimate 3000 HPLC systems equipped with
a Diode Array Detector (Thermo Fisher Scientific Inc.,
MA, USA). Separations were performed on a reversephase Luna C18 (150×4.6 mm i.d., 5 μm particle size)
analytical column (Phenomenex, Torrance, CA, USA).
Separation operated at a column oven temperature of
28°C at a flow rate of 0.6 mL/min. The mobile phases “A”
and “B” are water and acetonitrile, respectively. A 10 μL
injection volume was injected and elution gradient for
the separation as follows: initial 17% B, 0-12 min, 1725% B; 12-14 min, 25% B; 14-15 min, 25-17% B; 15-17
min, 17% B. Detection was carried out at a wavelength
of 360 nm. All samples were injected triplicate.
Cell Culture
A method described previously was used for cell
culture procedure (Su et al., 2016). WRL 68, HaCaT,
and CRL2522 cell lines were cultured in DMEM while

MCF-7 was cultured in RPMI media, and both media
supplemented with 5% FBS, 100 μM streptomycins,
and 100 U/mL penicillin. The culture condition is a
humidified atmosphere of 95% air plus 5% CO2 in a
37°C incubator. Cell count performed using a protocol
described by Cadena-Herrera et al. (2015).
MTT Assay
This assay was conducted following the method described
previously with modifications (Norfazlina et al., 2014).
After seeding 5x103 cells per well and incubation for
24 hours, 90% confluence cell culture in 96 wellplates was treated with 100 μL of extracts at different
concentration (0-5 mg/ml) and positive control (cisplatin
at 0.25 mM). After incubation at 37 °C for 24 hours, 20
μL MTT solution was added into each well and put in
the incubator for 4 hours. After incubation with DMSO
to stop the reaction, the absorbance value was measured
using a microplate reader at 570 nm. This assay was
repeated with cyclophosphamide treatment at different
concentrations (0-50 mM). The assay was also repeated
with a combination of extract and cyclophosphamide on
WRL 68 at a different ratio. IC50 and Combination Index
(CI) values were calculated, and isobolograms were
constructed.

Table 3. IC10, IC15, IC25, and IC50 of Cyclophosphamide on WRL 68
Treatment
Cyclophosphamide
(mM)

E-ISSN 2477-0612

IC10
(mean ± SEM)

IC15
(mean ± SEM)

IC25
(mean ± SEM)

IC50
(mean ± SEM)

0.264 ± 0.053

0.668 ± 0.105

2.156 ± 0.216

10.525 ± 0.244

Figure 3. IC50 (mean ± SEM) of antiproliferative activity of C.
nutans ethanolic extract against WRL 68, CRL 2522, MCF7, and
HaCaT cell lines. Bars with different letters denoted that the IC50
values were significantly different between cell lines (one-way
ANOVA, followed by posthoc Tukey’s test, p < 0.05)
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RESULTS
Aqueous and solvent extracts of C. nutans were
produced, and the yield of extraction was calculated. The
total phenolic content of the extracts was evaluated, and
HPLC analysis of the extracts phytochemical profiles
was conducted. The extraction yield of each extract was
calculated, and the result tabulated in Table 1.
For aqueous extract, the effect of extraction time on the
yield of extraction was evaluated. The result of Pearson’s
correlation analysis demonstrated a strong relationship
between extraction time and extraction yield of C.
nutans aqueous extract as the Pearson’s r value obtained
was 0.981. This analysis means changes in extraction
time strongly correlated to changes in extraction yield.
However, the correlation was not statistically significant
because the p-value was 0.125 (p > 0.05), which
means an increase or decrease in extraction time does
not cause significant changes in extraction yield. In
addition, the percent yield of the ethanolic extract was
the highest among all samples, which was 5.82%. It is
crucial to point out that extraction methods do affect the
phytochemical content in the extracts, such as phenolic
compounds. Therefore, total phenolic content (TPC) and
total flavonoid content (TFC) of the extracts C and D
were evaluated, and the results demonstrated in Figure 1.
Generally, gallic acid is used as the reference standard
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compound for TPC, and results are expressed as mg
gallic acid equivalent (GAE mg/g). The concentration of
total flavonoid content in the test samples was calculated
from the calibration plot and expressed as mg quercetin
equivalent (QE mg/g). There is no significant difference
in TPC of both extracts C and D. However, TFC of extract
D is significantly higher than of extract C.
HPLC profiling of aqueous extract (C) and ethanolic
extract (D) was conducted. From the chromatograms in
Figure 2, it showed that the phytochemical profiles of
both aqueous and ethanolic extracts were qualitatively
similar but quantitatively different in compositions. The
amount of flavonoid compounds is lesser in aqueous
extract (C) compared to in ethanolic extract (D).
Extract with the highest TPC and TFC, an ethanolic
extract (D), was screened for its antiproliferative activity
as preliminary evaluation. MTT assay was done to
evaluate the antiproliferative effect of the extract against
WRL 68 (normal liver), CRL2522 (normal fibroblast),
MCF7 (breast cancer), and HaCaT (immortalized
keratinocyte) cell lines. IC50 value of ethanolic extracts
were 3.86 ± 0.02 mg/ml, 7.10 ± 0.04 μg/ml, 2.42 ± 0.14
mg/ml and 4.78 ± 0.16, respectively, as summarized
in Figure 3. The results were expressed as the median
inhibitory concentration (IC50) mean ± SEM.

Table 4. Combination index
Combination
Treatment
CX + CN IC10
CX + CN IC15
CX + CN IC25

FIC CX

FIC CN

0.841
0.741
0.597

0.684
0.741
0.816

Combination
Index (CI)
1.525
1.482
1.413

Description
Antagonism
Antagonism
Antagonism

Figure 4. Proliferation inhibition (mean ± SEM) activity of Cyclophosphamide
(CX) (mM) against normal hepatocyte cell line (WRL 68). Cisplatin (CP) as a
positive control. Bars with different letters denoted that the mean values were
significantly different between treatments and untreated control (ANOVA
posthoc Tukey, p < 0.05).
E-ISSN 2477-0612
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Figure 5. Proliferation inhibition (mean ± SEM) activity of C. nutans
ethanolic extract (D) (mg/mL) against normal hepatocyte cell line (WRL
68). Cisplatin (CP) as a positive control. Bars with different letters denoted
that the mean values were significantly different between treatments and
untreated control (ANOVA posthoc Tukey, p < 0.05)

Figure 6. Isobologram of combination treatment of C. nutans
ethanolic extract (D) and cyclophosphamide against normal
hepatocyte cell line (WRL 68)
The effect of combination treatment of ethanolic extract
(D) and cyclophosphamide on WRL 68 (normal liver)
cell line was evaluated using MTT assay. Dose-response
curve for a single treatment of cyclophosphamide and
ethanolic extract (D) shown in Figure 4 and Figure
5, respectively. IC10, IC15, and IC50 value of single
treatment of ethanolic extract (D) and single treatment
of cyclophosphamide on WRL 68 (normal liver) cell
line were derived and tabulated in Table 2 and Table 3
respectively. Combination treatments were conducted
at concentration IC10 and IC15. The combination indexes
(CI) were calculated, and the CI values as listed in Table
4. The combination treatment of ethanolic extract (D)
and cyclophosphamide resulted in an antagonistic effect
as the CI values were above than one. In the isobologram
constructed as illustrated in Figure 6, the plots were
E-ISSN 2477-0612

falling above the line of additivity, which also indicated
antagonism.
DISCUSSION
For aqueous extract, the decoction method was chosen
to mimic traditional herbal tea preparation in herbal
medicine. Preparation of ethanolic extract involved the
sonication process and solvent removal, and both extracts
resulted in dried powdered form after lyophilization.
There are many factors affecting the yield of extraction,
such as pH of the aqueous sample, solvent type and
polarity, extraction time, number of extraction batch,
and also chemical constituents of the sample (Mokrani
& Madani, 2016).
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It was found that the decoction process did not
significantly decrease TPC of extract C. This is because
simple heating reportedly cannot cleave covalently
bound phenolic compounds. Heating at 150°C for 30 min
decreased the total phenolic content for onion varieties.
On the other hand, heating caused a significant decrease
in the TFC level as flavonoids to contain C- glycoside
bonds and exist as dimers and oligomers, and heating
or boiling results in hydrolysis of C-glycosides bonds
(Sharma et al., 2015). Apart from temperature, solvent
polarity does affect the phenolic content of the extracts.
Ethanol is an effective solvent to extract polyphenols,
flavonoids, alkaloids, and sterols while water dissolved
glycosides as well as alkaloids (Galanakis et al., 2013).
Phenols preference to polar protic solvents such as
ethanol and methanol is due to the formation of hydrogen
bonding between hydroxyl groups of the alcohol and
oxygen atom in the phenol molecules (Vuong et al.,
2014).
The extraction yield obtained for aqueous extract may
occur due to its high carbohydrates content that is
undetectable by UV-VIS spectra. In addition, apart
from the favourable polarity of ethanol in the recovery
of flavonoid compounds, the sonication process in
ethanolic extraction might contribute to a greater
amount of flavonoids identified in the ethanolic extract
as reflected in the chromatogram. Sonication assists the
destruction of cell walls thus enhancing better contact
and interaction between plant material and solvent
inside out. At low temperature, sonication improves the
extractability of compounds by the solvent (Annegowda
et al., 2011).
From the antiproliferative activity screening on a panel of
cell lines, it was found that the ethanolic extract (D) did
not exhibit the strong antiproliferative activity against
all cell lines. According to the National Cancer Institute
(NCI), a crude extract that exhibits an IC50 value <20 μg/
mL can be considered as an active anticancer agent.
This finding is supported by a previous study (Ng et al.,
2018), that reported 50, 70 and 100% ethanol extract of
C. nutans did not affect endothelial viability regardless of
its concentrations up to 100 μg/ml even with prolonged
treatment time from 24 to 72 hours. The antiproliferative
activity of ethanolic extract (D) is the highest against
MCF7 (breast cancer) and the lowest against CRL2522
(normal fibroblast) cell line. On WRL 68 (normal liver)
and HaCaT (keratinocyte) the extract showed moderate
inhibition of proliferation. This indicates that the
ethanolic extract of C. nutans displayed tumor-specific
antiproliferative activity in comparison to normal cells.
The previous study suggested that the mechanism of
action that responsible for antitumor activity of phenolic
compounds include generation of the intolerable amount
of H2O2 by polyphenols which induce cell apoptosis
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as well as prevention of cancer cell growth by inducing
oxidative stress within the cell via neutralization of free
radicals and scavenging reactive oxygen species (ROS)
(Malta et al., 2013).
However, in the literature, a low correlation between
TPC and antiproliferative activity in some plant extracts
was reported (Tauchen et. al., 2016). Another study
also could not find a clear correlation between TPC and
antiproliferative activity of extract thus suggested in vitro
tumor cell proliferation inhibition cannot be justified
solely by the concentration of phenolic or flavonoid
compounds because other phytochemical constituents
of the extract might contribute a vital role in its antiproliferative activity (Malta et. al., 2013). Water-soluble
portion of C. nutans stems and leaves extracts is rich in
C-glycosyl flavones that were successfully isolated in
the previous study, which include schaftoside, vitexin,
isovitexin, orientin, isoorientin, and isomollupentin 7-Ob- glucopyranoside. These flavones might be as well
responsible for the antiproliferative activity of C. nutans
(Sakdarat et al., 2009).
Although the polar extracts of C. nutans were reported to
have low antiproliferative activity, patients that undergo
chemotherapy treatment still consume plant product
such as C. nutans tea as complementary treatment
without knowing its effects on chemotherapy. Drug-herb
interactions may affect drug efficacy in several ways,
potentially result in an antagonistic, additive, or synergistic
effect. As a prodrug, cyclophosphamide undergoes
metabolism by hepatic cytochrome P450 isozymes
through the activation process by 4-hydroxylation
pathway generating 4-hydroxycyclophosphamide that
forms cytotoxic phosphoramide mustard as well as byproduct acrolein (Chen et al., 2004). The mechanism
of antagonistic interaction between C. nutans ethanolic
extract (D) and cyclophosphamide on WRL 68 (normal
liver) cell line is not known. However, alteration of the
CYP450 enzyme activity or expression could affect the
efficacy of the drug treatment. A previous study reported
that flavonoids contained in grapefruit juice inhibit CYP
450, bind as a substrate to the enzyme system, and disrupt
drug bioavailability (Say et al., 2017). Since C. nutans
ethanolic extract contains high flavonoids level, it could
potentially interact with CYP 450 enzymes of the cell
line that may have affected metabolism and activation
of the drug.
CONCLUSION
In conclusion, this study suggested that there was a
potential antagonistic drug-herb posed by C. nutans
ethanolic extract, which could impair the efficacy of
cyclophosphamide treatment. Further investigation
should be done in vivo and clinical research models to
support these in vitro data.
E-ISSN 2477-0612
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